Actinium Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2001 | — | $-1.7M | — |
| FY2002 | — | $-1.7M | — |
| FY2003 | — | $1.6M | — |
| FY2004 | — | $439.1K | — |
| FY2005 | — | $74.3K | — |
| FY2006 | — | $1.8M | — |
| FY2007 | — | $3.5M | — |
| FY2008 | — | $4.2M | — |
| FY2009 | — | $845.2K | $2.1K |
| FY2010 | — | $399.1K | $196.1K |
| FY2011 | — | $992.0K | $5.7M |
| FY2012 | — | $1.1M | $5.6M |
| FY2013 | — | $-1.6M | $5.5M |
| FY2014 | — | $-1.9M | $6.7M |
| FY2015 | — | $22.0M | $25.6M |
| FY2016 | — | $18.0M | $20.5M |
| FY2017 | — | $13.7M | $17.4M |
| FY2018 | — | $8.8M | $13.7M |
| FY2019 | $900.0K | $5.6M | $9.3M |
| FY2020 | — | $61.3M | $63.6M |
| FY2021 | — | $73.5M | $77.8M |
| FY2022 | — | $66.5M | $108.9M |
| FY2023 | — | $36.4M | $76.7M |
| FY2024 | — | $32.8M | $72.9M |
| FY2025 | — | $7.8M | $48.0M |